COST PLUS DRUGS

Serial Number 97307445
Registration 7582440
700

Registration Progress

Application Filed
Mar 11, 2022
Under Examination
Approved for Publication
Published for Opposition
Registered
Nov 26, 2024

Trademark Image

COST PLUS DRUGS

Basic Information

Serial Number
97307445
Registration Number
7582440
Filing Date
March 11, 2022
Registration Date
November 26, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Nov 26, 2024
Registration
Registered
Classes
005

Rights Holder

Mark Cuban Cost Plus Drug Company, PBC

03
Address
8712 W Fair Dr
Littleton, CO 80123

Ownership History

Mark Cuban Cost Plus Drug Company, PBC

Original Applicant
03
Littleton, CO

Mark Cuban Cost Plus Drug Company, PBC

Original Registrant
03
Littleton, CO

Legal Representation

Attorney
Diana Rutowski & Seth Reagan

Application History

32 events
Date Code Type Description Documents
Nov 26, 2024 NRCS E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Nov 26, 2024 R.SR A REGISTERED-SUPPLEMENTAL REGISTER Loading...
Oct 30, 2024 CNTA O APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER Loading...
Oct 29, 2024 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Oct 29, 2024 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Oct 29, 2024 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Oct 29, 2024 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Oct 22, 2024 IUAA P USE AMENDMENT ACCEPTED Loading...
Oct 1, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 20, 2024 ALIE A ASSIGNED TO LIE Loading...
Sep 20, 2024 AUPC I AMENDMENT TO USE PROCESSING COMPLETE Loading...
May 13, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 13, 2024 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
May 9, 2024 IUAF S USE AMENDMENT FILED Loading...
May 9, 2024 EAAU I TEAS AMENDMENT OF USE RECEIVED Loading...
Feb 12, 2024 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
Feb 12, 2024 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
Nov 15, 2023 GNFR O FINAL REFUSAL E-MAILED Loading...
Nov 15, 2023 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Nov 15, 2023 CNFR R FINAL REFUSAL WRITTEN Loading...
Apr 28, 2023 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Apr 28, 2023 GNSL S LETTER OF SUSPENSION E-MAILED Loading...
Apr 28, 2023 CNSL R SUSPENSION LETTER WRITTEN Loading...
Mar 10, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 10, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 10, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 28, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Dec 28, 2022 GNRT F NON-FINAL ACTION E-MAILED Loading...
Dec 28, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Dec 22, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 16, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 15, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
House mark for a full line of pharmaceutical preparations
First Use Anywhere: 20240500
First Use in Commerce: 20240500

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"DRUGS"